Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CDC will - over the next 2 Weeks and hit - by . In that time frame, CDC's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
CDC shares rose +0.37% in Friday, September 11, 2026's trading session, rising from a previous close of $75.14 to move at $75.42. The stock demonstrated notable intraday movement (see CDC's key stats for a full breakdown), fluctuating between $75.23 and $75.77, a +0.72% trading range. While recent weeks have seen some volatility, CDC has managed to secure a -1.91% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 11.25K shares changing hands, 3.78K fewer than the previous session. This amounted to $848.19K in total market activity.
Will CDC Continue Its Trend?
According to analyst ratings and projections for CDC, VictoryShares US EQ Income Enhanced Volatility Wtd ETF shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for CDC currently suggest a bearish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the CDC stock forecast, now is not the best time to buy CDC stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on CDC covering social and institutional perspectives.
CDC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CDC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 34.72% to 44.10%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 51.13%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.37%, maintains a neutral outlook for the long term. Insights into CDC's shareholder base show how institutional investors are positioning themselves during these momentum shifts

